•
Sep 30, 2023

DaVita Q3 2023 Earnings Report

DaVita reported a strong third quarter in 2023, demonstrating progress across key operating priorities and balancing near-term discipline with investments in future growth.

Key Takeaways

DaVita Inc. announced strong financial results for the third quarter of 2023, with consolidated revenues of $3.1 billion, operating income of $496 million, and diluted earnings per share of $2.62. The company has balanced operating discipline with investments in future growth, while focusing on teammate experience and patient care.

Consolidated revenues reached $3.1 billion.

Operating income was $496 million, with an adjusted operating income of $525 million.

Diluted earnings per share (EPS) stood at $2.62, and adjusted diluted EPS was $2.85.

Operating cash flow amounted to $661 million, while free cash flow reached $453 million.

Total Revenue
$3.12B
Previous year: $2.95B
+5.8%
EPS
$2.85
Previous year: $1.45
+96.6%
US Dialysis Treatments
7.31M
Previous year: 7.34M
-0.4%
US Avg Treatments per day
92.49K
Previous year: 92.86K
-0.4%
US Revenue per Treatment
$380
Previous year: $368
+3.4%
Gross Profit
$1.05B
Previous year: $863M
+22.1%
Cash and Equivalents
$449M
Previous year: $368M
+22.3%
Free Cash Flow
$453M
Previous year: $500M
-9.4%
Total Assets
$16.9B
Previous year: $17B
-0.2%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided its 2023 guidance for adjusted operating income, adjusted diluted net income per share, and free cash flow.

Positive Outlook

  • Adjusted operating income is expected to be between $1,650 million and $1,725 million.
  • Adjusted diluted net income per share is projected to be in the range of $7.80 to $8.30.
  • Free cash flow is anticipated to be between $950 million and $1,150 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income